Sabin Vaccine Institute Awarded Funding to Advance Therapeutic Vaccine Development for Chagas Disease

WASHINGTON, D.C. — September 16, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) received $2 million from the Global Health Innovative Technology Fund (GHIT Fund) to develop a new therapeutic vaccine formulation for Chagas disease. Baylor College of Medicine, Eisai Co., Ltd. (Eisai) and Aeras are partnering on this project with the Sabin PDP, based at the Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development in Houston, Texas.

Phase 1 Clinical Trial of Human Hookworm Vaccine Successfully Completed

WASHINGTON, D.C. — September 3, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) successfully completed a Phase 1 clinical trial in Brazil of Na-GST-1/Alhydrogel®, a vaccine candidate for human hookworm, one of the most pervasive neglected tropical diseases (NTDs) affecting the world’s poor. The Sabin PDP is based at Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine in Houston, Texas.

Eleventh International Rotavirus Symposium Held in New Delhi, India

New Delhi, India — September 3, 2014 — The Eleventh International Rotavirus Symposium today began just two months after Indian Prime Minister Narendra Modi announced that the Government of India would provide a rotavirus vaccine to all Indian children, and weeks before the highly anticipated UN General Assembly’s 69th opening session, which will assess progress towards the Millennium Development Goals (MDGs).

Statement by the Sabin Vaccine Institute on the introduction of the “End Neglected Tropical Diseases Act”

On June 11, 2014, Congressman Chris Smith (R-NJ) introduced a bipartisan bill in the House of Representatives to support the control and elimination of neglected tropical diseases (NTDs) in the United States and abroad. H.R. 4847, the “End Neglected Tropical Diseases Act,” calls for the expansion of USAID’s NTD program; increased U.S. Government advocacy for NTDs among international development and financing institutions; reporting from the U.S. Department of Health and Human Services on NTDs in the United States; the creation of one or more NTD centers of excellence to increase research and development (R&D); and the establishment of a panel on intestinal worm infections, one of the most pervasive NTDs.

Statements by the Sabin Vaccine Institute on the passing of Executive Vice President Ciro de Quadros, MD

Dr. Ciro de Quadros, a public health hero and the Sabin Vaccine Institute’s Executive Vice President and Director of Vaccine Advocacy and Education, passed away peacefully today at his home in Washington, DC, surrounded by his family. The following are statements from Sabin’s executive leadership reflecting on the profound difference that Ciro made during his lifetime.

Statement by the Sabin Vaccine Institute: A rare spotlight for a neglected disease

Schistosomiasis, a parasitic disease transmitted by freshwater snails, infects more than 200 million people worldwide, causing horrific symptoms, especially in girls and women. Schistosomiasis is the second deadliest parasitic disease after malaria, killing an estimated 300,000 people annually, and has been linked as a co-factor in the spread of HIV/AIDS in sub-Saharan Africa and the incidence of bladder cancer.

Statement by the Sabin Vaccine Institute on Dr. Ciro de Quadros’ PAHO Public Health Hero of the Americas Award

Dr. Ciro de Quadros, Sabin Vaccine Institute’s Executive Vice President and Director of Vaccine Advocacy and Education, received the Public Health Hero of the Americas Award on April 25, 2014. The award is the highest honor bestowed by the Pan American Health Organization (PAHO). It was announced during Sabin’s 20th Anniversary Scientific Symposium, which was held at PAHO headquarters in Washington, DC.

Dr. Mathuram Santosham Receives 2014 Albert B. Sabin Gold Medal Award

WASHINGTON, D.C. – April 29, 2014 – The Sabin Vaccine Institute today will present its annual Albert B. Sabin Gold Medal Award to Dr. Mathuram Santosham for his pioneering role in the prevention of deadly H. influenzae type b (Hib) diseases, including pediatric bacterial meningitis and pneumonia. Dr. Santosham’s leadership in conducting groundbreaking research, vaccine efficacy trials and advocacy to prioritize Hib vaccines spans more than 40 years and has saved millions of children’s lives worldwide.

Sabin Vaccine Institute Hosts 20th Anniversary Scientific Symposium

WASHINGTON, D.C. – April 25, 2014 – Twenty years ago, the immunization landscape was starkly different from what it is now. More than 100,000 cases of poliomyelitis and 1.2 million cases of measles occurred each year, and few low-income countries outside of the Americas had immunization plans. Neglected tropical diseases (NTDs), which have existed since biblical times, wreaked havoc without recognition due to an absence of coordinated advocacy and government funding.

Pages